Table 3. Multivariable Linear Mixed Effects Regression Analysis of the Corrected QT Interval in Malaria Following Treatment with Amodiaquine.
QTcS – Study-specific Correction (milliseconds) | QTcF – Fridericia Correction (milliseconds) | QTcB – Bazett Correction (milliseconds) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Univariable Analyses | Multivariable Analyses | Univariable Analyses | Multivariable Analyses | Univariable Analyses | Multivariable Analyses | ||||||||
Number of Observations | Crude Estimate (95% CI) | p value | Adjusted Estimate (95% CI) | p value | Crude Estimate (95% CI) | p value | Adjusted Estimate (95% CI) | p value | Crude Estimate (95% CI) | p value | Adjusted Estimate (95% CI) | p value | |
Total plasma concentration of amodiaquine and desethylamodiaquine, per 750* nmol/litre increase | 356 | 12.98 (8.73 to 17.16) | <0.0001 | 10.43 (5.92 to 15.00) | <0.0001 | 20.35 (15.56 to 25.15) | <0.0001 | 10.67 (6.13 to 15.21) | <0.0001 | 6.10 (1.80 to 10.38) | 0.0055 | 10.26 (5.71 to 14.81) | <0.0001 |
Body temperature change, per 1°C increase | 356 | -5.30 (-7.12 to -3.47) | <0.0001 | -3.97 (-6.49 to -1.46) | 0.0021 | -10.59 (-12.52 to -8.65) | <0.0001 | -4.04 (-6.57 to -1.52) | 0.0018 | -0.374 (-2.25 to 1.50) | 0.6948 | -3.90 (-6.43 to -1.37) | 0.0026 |
Sex | 356 | ||||||||||||
Female | 187 | Reference | Reference | Reference | Reference | Reference | Reference | ||||||
Male | 169 | -16.24 (-25.48 to -7.00) | 0.0009 | -17.35 (-26.62 to -8.08) | 0.0004 | -12.72 (-22.11 to -3.34) | 0.0088 | -13.30 (-22.94 to -3.66) | 0.0078 | -19.54 (-29.00 to -10.08) | 0.0001 | -21.05 (-30.57 to -11.52) | <0.0001 |
Age, per 10-year increase | 356 | 2.33 (-0.25 to 0.71) | 0.3339 | 4.16 (-0.17 to 8.49) | 0.0595 | 2.87 (-1.78 to 7.52) | 0.2209 | 4.47 (-0.30 to 8.98) | 0.0515 | 1.78 (-3.32 to 6.88) | 0.4859 | 3.87 (-0.57 to 8.32) | 0.0864 |
RR interval change, per 300-millisecond increase | 356 | 7.50 (4.46 to 10.54) | <0.0001 | -0.42 (-4.80 to 3.95) | 0.8475 | 19.69 (16.65 to 22.74) | <0.0001 | 11.63 (7.25 to 16.01) | <0.0001 | -3.69 (-6.75 to -0.65) | 0.0177 | -11.45 (-15.84 to -7.06) | <0.0001 |
, where RR is in units of seconds
Mean maximum total plasma drug concentration (rounded) after a 3-day course of amodiaquine from pharmacokinetic analysis of same study
Mean change in RR interval from baseline (rounded) after last dose of amodiaquine treatment in this study